Anti-Purkinje cell antibody as a biological marker in attention deficit/hyperactivity disorder: A pilot study

Journal of Neuroimmunology

Volumn 258, Issue 1-2, 2013, Pages 67-70

  Passarelli, Francesca ^a   Donfrancesco, Renato ^b   Nativio, Paola ^a   Pascale, Esterina ^a   Trani, Michela Di ^a   Patti, Anna Maria ^a   Vulcano, Antonella ^a   Gozzo, Paolo ^a   Villa, Maria Pia ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ADHD; Anti Yo antibodies; Cerebellum; Immunofluorescence; Purkinje cells

Indexed keywords

BIOLOGICAL MARKER; CELL ANTIBODY; HU ANTIBODY; UNCLASSIFIED DRUG; YO ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; ATTENTION DEFICIT DISORDER; CEREBELLUM; CHILD; CLINICAL EVALUATION; CONDUCT DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DYSLEXIA; FEMALE; HUMAN; IMMUNE DYSREGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OPPOSITIONAL DEFIANT DISORDER; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHOOL CHILD; WESTERN BLOTTING;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; PILOT PROJECTS; PURKINJE CELLS;

EID: 84876720088     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.02.018     Document Type: Article

References (24)

1. Ashtari M., Kumra S., Bhaskar S.L., Clarke T., Thaden E., Cervellione K.L., Rhinewine J., Kane J.M., Adesman A., Milanaik R., Maytal J., Diamond A., Szeszko P., Ardekani B.A. Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol. Psychiatry 2005, 57:448-455.
2. Berquin P.C., Giedd J.N., Jacobsen L.K., Hamburger S.D., Krain A.L., Rapoport J.L., Castellanos F.X. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 1998, 50:1087-1093.
3. Castellanos F.X., Acosta M.T. Syndrome of attention deficit with hyperactivity as the expression of an organic functional disorder. Rev. Neurol. 2002, 35:1-11.
4. Castellanos F.X., Lee P.P., Sharp W., Jeffries N.O., Greenstein D.K., Clasen L.S., Blumenthal J.D., James R.S., Ebens C.L., Walter J.M., Zijdenbos A., Evans A.C., Giedd J.N., Rapoport J.L. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002, 288:1740-1748.
5. Church A.J., Cardoso F., Dale R.C., Lees A.J., Thompson E.J., Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 2002, 59:227-231.
6. Church A.J., Dale R.C., Lees A.J., Giovannoni G., Robertson M.M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J. Neurol. Neurosurg. Psychiatry 2003, 74:602-607.
7. Darnell R.B., Posner J.B. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 2003, 349:1543-1554.
8. DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale - IV 1998, Guilford Publications, New York.
9. Faraone S.V., Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J. Atten. Disord. 2005, 9:384-391.
10. Hollingshead A. Four Factor Index of Social Status 1957, Yale University Department of Sociology, New Haven.
11. Ito M. Control of mental activities by internal models in the cerebellum. Nat. Rev. Neurosci. 2008, 9:304-313.
12. Ivry R.B., Spencer R.M., Zelaznik H.N., Diedrichsen J. The cerebellum and event timing. Ann. N. Y. Acad. Sci. 2002, 978:302-317.
13. Job R., Sartori G., Tressoldi P.E. Battery for the Evaluation of Dyslexia and Dysorthographia 1995, Organizzazioni Speciali, Firenze, Italy.
14. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., Ryan N. Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime version, (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36:980-988.
15. Kirvan C.A., Swedo S.E., Heuser J.S., Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 2003, 9:914-920.
16. Mackie S., Shaw P., Lenroot R., Pierson R., Greenstein D.K., Nugent T.F., Sharp W.S., Giedd J.N., Rapoport J.L. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. Am. J. Psychiatry 2007, 164:647-655.
17. Marzocchi G.M., Cornoldi C. Una scala di facile uso per la rilevazione dei comportamenti problematici dei bambini con deficit di attenzione e iperattività. Psicol. Clin. Svilupp. 2000, 4:43-64.
18. Murphy K., Barkley R.A. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr. Psychiatry 1996, 37:393-401.
19. Pavone P., Bianchini R., Parano E., Incorpora G., Rizzo R., Mazzone L., Trifiletti R.R. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr. Neurol. 2004, 30:107-110.
20. Schmahmann J.D., Sherman J.C. The cerebellar cognitive affective syndrome. Brain 1998, 121:561-579.
21. Semrud-Clikeman M., Steingard R.J., Filipek P., Biederman J., Bekken K., Renshaw P.F. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39:477-484.
22. Singer H.S., Loiselle C.R., Lee O., Minzer K., Swedo S., Grus F.H. Anti-basal ganglia antibodies in PANDAS. Mov. Disord. 2004, 19:406-415.
23. Taylor J.R., Morshed S.A., Parveen S., Mercadante M.T., Scahill L., Peterson B.S., King R.A., Leckman J.F., Lombroso P.J. An animal model of Tourette's syndrome. Am. J. Psychiatry 2002, 159:657-660.
24. Wechsler D. WISC-III 1991, NCS Pearson Inc., USA.